Tags

Type your tag names separated by a space and hit enter

Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Nat Genet. 2020 Oct; 52(10):1132.NGen

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Lunardi A
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Ala U
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Department of Genetics, Biology and Biochemistry, Molecular Biotechnology Center, University of Turin, Turin, Italy.
Epping MT
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Salmena L
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Clohessy JG
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Webster KA
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Wang G
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Biochemistry, Cell & Molecular Biology Program, Weill Graduate School of Medical Sciences, Cornell University, New York, NY, USA.
Mazzucchelli R
Institute of Pathological Anatomy and Histopathology, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy.
Bianconi M
Clinic of Oncology, Postgraduate School in Medical Oncology, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy.
Stack EC
Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lis R
Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Patnaik A
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Cantley LC
Department of Systems Biology, Harvard Medical School, Boston, MA, USA. Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Bubley G
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Cordon-Cardo C
Department of Genetics and Genomic Sciences, The Mount Sinai School of Medicine, New York, NY, USA.
Gerald WL
Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Montironi R
Institute of Pathological Anatomy and Histopathology, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy.
Signoretti S
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Loda M
Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Nardella C
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Pandolfi PP
Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. ppandolf@bidmc.harvard.edu. Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. ppandolf@bidmc.harvard.edu. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. ppandolf@bidmc.harvard.edu.

Pub Type(s)

Published Erratum

Language

eng

PubMed ID

32884149

Citation

Lunardi, Andrea, et al. "Author Correction: a Co-clinical Approach Identifies Mechanisms and Potential Therapies for Androgen Deprivation Resistance in Prostate Cancer." Nature Genetics, vol. 52, no. 10, 2020, p. 1132.
Lunardi A, Ala U, Epping MT, et al. Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2020;52(10):1132.
Lunardi, A., Ala, U., Epping, M. T., Salmena, L., Clohessy, J. G., Webster, K. A., Wang, G., Mazzucchelli, R., Bianconi, M., Stack, E. C., Lis, R., Patnaik, A., Cantley, L. C., Bubley, G., Cordon-Cardo, C., Gerald, W. L., Montironi, R., Signoretti, S., Loda, M., ... Pandolfi, P. P. (2020). Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics, 52(10), 1132. https://doi.org/10.1038/s41588-020-0701-7
Lunardi A, et al. Author Correction: a Co-clinical Approach Identifies Mechanisms and Potential Therapies for Androgen Deprivation Resistance in Prostate Cancer. Nat Genet. 2020;52(10):1132. PubMed PMID: 32884149.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. AU - Lunardi,Andrea, AU - Ala,Ugo, AU - Epping,Mirjam T, AU - Salmena,Leonardo, AU - Clohessy,John G, AU - Webster,Kaitlyn A, AU - Wang,Guocan, AU - Mazzucchelli,Roberta, AU - Bianconi,Maristella, AU - Stack,Edward C, AU - Lis,Rosina, AU - Patnaik,Akash, AU - Cantley,Lewis C, AU - Bubley,Glenn, AU - Cordon-Cardo,Carlos, AU - Gerald,William L, AU - Montironi,Rodolfo, AU - Signoretti,Sabina, AU - Loda,Massimo, AU - Nardella,Caterina, AU - Pandolfi,Pier Paolo, PY - 2020/9/5/pubmed PY - 2020/9/5/medline PY - 2020/9/5/entrez SP - 1132 EP - 1132 JF - Nature genetics JO - Nat Genet VL - 52 IS - 10 N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper. SN - 1546-1718 UR - https://www.unboundmedicine.com/medline/citation/32884149/Author_Correction:_A_co_clinical_approach_identifies_mechanisms_and_potential_therapies_for_androgen_deprivation_resistance_in_prostate_cancer_ DB - PRIME DP - Unbound Medicine ER -